[HTML][HTML] Sofosbuvir and velpatasvir for HCV genotype 1, 2, 4, 5, and 6 infection
…, C Moreno, E Yoshida, SD Shafran… - … England Journal of …, 2015 - Mass Medical Soc
Background A simple treatment regimen that is effective in a broad range of patients who
are chronically infected with the hepatitis C virus (HCV) remains an unmet medical need. …
are chronically infected with the hepatitis C virus (HCV) remains an unmet medical need. …
[HTML][HTML] Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV genotype 2 or 3
…, D Nelson, H Harley, R Solá, SD Shafran… - … England Journal of …, 2007 - Mass Medical Soc
Background Patients infected with hepatitis C virus (HCV) genotype 2 or 3 have sustained
virologic response rates of approximately 80% after receiving treatment with peginterferon …
virologic response rates of approximately 80% after receiving treatment with peginterferon …
[HTML][HTML] A Comparison of Two Regimens for the Treatment of Mycobacterium avium Complex Bacteremia in AIDS: Rifabutin, Ethambutol, and Clarithromycin versus …
SD Shafran, J Singer, DP Zarowny… - … England Journal of …, 1996 - Mass Medical Soc
Background Bacteremia with the Mycobacterium avium complex is common in patients with
the acquired immunodeficiency syndrome (AIDS), but the most effective treatment for this …
the acquired immunodeficiency syndrome (AIDS), but the most effective treatment for this …
Infective endocarditis: review of 135 cases over 9 years
RM Sandre, SD Shafran - Clinical infectious diseases, 1996 - academic.oup.com
One hundred thirty-five cases of infective endocarditis in adults at the University of Alberta
Hospital from 1985 to 1993 were reviewed and the von Reyn and Duke criteria were compared…
Hospital from 1985 to 1993 were reviewed and the von Reyn and Duke criteria were compared…
Identification of a novel hepatitis C virus genotype from Punjab, India: expanding classification of hepatitis C virus into 8 genotypes
…, H Mo, E Svarovskaia, SD Shafran - The Journal of …, 2018 - academic.oup.com
Background Hepatitis C virus (HCV) exhibits great genetic diversity and is classified into 7
genotypes (GTs), with varied geographic prevalence. Until the recent development of …
genotypes (GTs), with varied geographic prevalence. Until the recent development of …
Efficacy of 8 weeks of sofosbuvir, velpatasvir, and voxilaprevir in patients with chronic HCV infection: 2 phase 3 randomized trials
…, PJ Ruane, RG Nahass, SM Borgia, SD Shafran… - Gastroenterology, 2017 - Elsevier
Background & Aims Patients with chronic hepatitis C virus (HCV) infection have high rates
of sustained virologic response (SVR) after 12 weeks of treatment with the nucleotide …
of sustained virologic response (SVR) after 12 weeks of treatment with the nucleotide …
Acute bacterial meningitis in adults: a 12-year review
AS Hussein, SD Shafran - Medicine, 2000 - journals.lww.com
… Hussein, Ahmed S.; Shafran, Stephen D. … Stephen D. Shafran, Division of Infectious
Diseases, Department of Medicine, University of Alberta, 2E4.11 Walter C. Mackenzie …
Diseases, Department of Medicine, University of Alberta, 2E4.11 Walter C. Mackenzie …
Effectiveness of elbasvir and grazoprevir combination, with or without ribavirin, for treatment-experienced patients with chronic hepatitis C infection
…, B Pearlman, JM Vierling, L Serfaty, M Buti, S Shafran… - Gastroenterology, 2017 - Elsevier
Background & Aims Patients infected with hepatitis C virus (HCV) genotype 1, 4, or 6, with or
without cirrhosis, previously treated with peg-interferon and ribavirin, are a challenge to treat…
without cirrhosis, previously treated with peg-interferon and ribavirin, are a challenge to treat…
[HTML][HTML] Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational postexposure prophylaxis
…, G Lambert, B Lebouche, G Metz, T Rogers, S Shafran - Cmaj, 2017 - Can Med Assoc
… Stephen Shafran reports grants from AbbVie, Gilead and Janssen; grants and personal
fees from Merck and BMS; and personal fees from Pfizer, outside the submitted work. No other …
fees from Merck and BMS; and personal fees from Pfizer, outside the submitted work. No other …
Management of chronic hepatitis C: consensus guidelines
M Sherman, S Shafran, K Burak, K Doucette… - Canadian Journal of …, 2007 - hindawi.com
Since the last consensus conference on the management of chronic viral hepatitis, a number
of studies looking at modifications of the standard course of treatment have been published…
of studies looking at modifications of the standard course of treatment have been published…
